Brief: Acadia Pharmaceuticals Q3 EPS USD 0.42
05/11/2025 21:05
Nov 05 (Reuters) - Acadia Pharmaceuticals Q3 product sales USD 278.633 million. Q3 net income USD 71.779 million Q3 pretax profit USD 44.595 million Q3 operating expenses USD 242.877 million
Recent news on Acadia Pharmaceuticals
See all newsUS RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
Acadia's Alzheimer's psychosis drug misses main goal of mid-stage study (updated)
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry